Medtronic (MDT) ended the recent trading session at $90.19, demonstrating a +1.05% swing from the preceding day's closing price. The stock outpaced the S&P 500's daily loss of 0.29%. Elsewhere, the ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

The Inceptiv data give Medtronic more evidence as it tries to increase sales of a product that drove double-digit growth at ...

He succeeds Karen Parkhill, the CFO since 2016 who officially ended her tenure on Aug. 2 to join the tech giant HP as finance ...

Medtronic on Tuesday named an alum of General Electric and French automaker Renault Group to become its new chief financial ...

Medtronic said on Tuesday it will appoint Renault's finance chief Thierry Piéton as its chief financial officer, effective ...

Medicare may begin to cover renal denervation with Medtronic’s Symplicity device by October, which could drive coverage among ...

Medtronic (NYSE: MDT) today announced 12-month data demonstrating the benefits of its Inceptiv closed-loop spinal cord stimulator (CL-SCS).

Medtronic (NYSE: MDT) announced today that it appointed Thierry Piéton as its new chief financial officer (CFO), effective ...

Shares of Medtronic (MDT) traded marginally lower on Thursday after rising from a low of $80.01 from the past six trading sessions, where shares soared overall ...

Medtronic (NYSE: MDT) has named Thierry Piéton, currently the chief financial officer of automaker Renault Group, as its next ...

In a report released today, Richard Newitter from Truist Financial maintained a Hold rating on Medtronic (MDT – Research Report). The company’s ...